ERN2 and thyroid gland carcinoma: In particular, ERN2, a UPR marker, was highly expressed in adrenal medullary tumor and PitNET datasets obtained by ACME HS and nuclei isolation methods, in adrenocortical tumors by enzymatic digestion, and in thyroid carcinomas by the ACME HS method.